100 Cyberonics Boulevard
United States - Map
Cyberonics, Inc., together with its subsidiaries, designs, develops, markets, and sells implantable medical devices to hospitals and ambulatory surgery centers. The company offers vagus nerve stimulation (VNS) therapy system that uses pulsed electrical signals applied to the vagus nerve for the treatment of refractory epilepsy and treatment-resistant depression. It is also engaged in investigating the use of VNS and other neuromodulation therapy for other indications, including chronic heart failure, and developing non-implantable device solutions for the management of epilepsy. The company sells its products directly, as well as through independent distributors in Europe, Canada, Mexico, Australia, parts of Central and South America, the Middle East, China, Japan, and other parts of Asia. Cyberonics, Inc. was founded in 1987 and is headquartered in Houston, Texas.
|Cyberonics Inc.’s ISS Governance QuickScore as of May 1, 2015 is 3. The pillar scores are Audit: 1; Board: 1; Shareholder Rights: 4; Compensation: 5.|
|Brought to you by Institutional Shareholder Services (ISS)|
|Mr. Daniel Jeffrey Moore ,
Chief Exec. Officer, Pres and Exec. Director
|Mr. Gregory H. Browne ,
Chief Financial Officer, Principal Accounting Officer and Sr. VP of Fin.
|Mr. Rohan J. Hoare ,
Chief Operating Officer and Sr. VP
|Mr. David S. Wise ,
Chief Admin. Officer, Sr. VP and Sec.
|Mr. Darren W. Alch ,
VP, Compliance Officer, Gen. Counsel and Assistant Sec.
|Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|